Another Oops. [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2011-11-25 15:23 (4909 d 06:41 ago) – Posting: # 7724
Views: 8,625

Dear Detlew!

❝ Inspecting it I have some doubts:

❝ ❝ […] some nonsense code


❝ Must the EMA guidance interpreted in this way, i.e. analysing the dataset with 'pseudo' periods and sequences? Or should it interpreted the way which is employed in the Q&A for the replicate design (intra-subject variability of the reference). That means only massacre out the data concerning R2 but retaining the original periods and sequences. :ponder:


Exactly! Should forget copypasting old code when new ‘knowledge’ became available in the meantime. :-(

❝ ❝ FMMSE     <- summary(FullModel)$sigma^2/FMdf

❝ At least the code for FMMSE has stolen my sleep :confused:. According to the help page of lm.summary() "... sigma - the square root of the estimated variance of the random error" and IMHO then the MSE is sigma^2 without the division by the degrees of freedom!


Oh s**t!

❝ Check this out via anova(FullModel)["Residuals","Mean Sq"]==summary(FullModel)$sigma^2 .

❝ Or did I miss sumfink here?


No, no. Sorry!

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,667 registered users;
66 visitors (0 registered, 66 guests [including 7 identified bots]).
Forum time: 23:04 CEST (Europe/Vienna)

Patients may recover in spite of drugs or because of them.    John Gaddum

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5